glp-1 covid Agonists May Help People With Diabetes and Long Staying in Scope: Understanding COVID-19
Description
Oral semaglutide at doses of 7 and 14 mg/day reduced HbA1c and body weight across the entire spectrum of DM2, as well as other endpoints, such as fasting blood glucose
Unfortunately, such a clinical trial has not yet been performed
Adapting to a change in medication will often interrupt a patients weight-loss trajectory, she said, and the trial-and-error could create a lot of waste for medications that were in shortage not long ago
Bioinformatic analyses on publicly-available patient RNA-sequencing data (n=664) identified significantly higher GLP1R expression in advanced prostate cancer vs
Gault et al
